135 related articles for article (PubMed ID: 9665300)
1. Purulent pleurisy caused by Campylobacter lari.
Bruneau B; Burc L; Bizet C; Lambert-Zechovsky N; Branger C
Eur J Clin Microbiol Infect Dis; 1998 Mar; 17(3):185-8. PubMed ID: 9665300
[TBL] [Abstract][Full Text] [Related]
2. Fatal relapse of a purulent pleurisy caused by Campylobacter fetus subsp. fetus.
Decousser JW; Prouzet-Mauléon V; Bartizel C; Gin T; Colin JP; Fadel N; Holler C; Pollet J; Megraud F
J Clin Microbiol; 2007 Jul; 45(7):2334-6. PubMed ID: 17507518
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic susceptibility profiles among Campylobacter isolates obtained from international travelers between 2007 and 2014.
Post A; Martiny D; van Waterschoot N; Hallin M; Maniewski U; Bottieau E; Van Esbroeck M; Vlieghe E; Ombelet S; Vandenberg O; Jacobs J
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2101-2107. PubMed ID: 28623550
[TBL] [Abstract][Full Text] [Related]
4. Effect of clavulanic acid on susceptibility of Campylobacter jejuni and Campylobacter coli to eight beta-lactam antibiotics.
Gaudreau CL; Lariviere LA; Lauzer JC; Turgeon FF
Antimicrob Agents Chemother; 1987 Jun; 31(6):940-2. PubMed ID: 3619428
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of tigecycline (GAR-936) and other antimicrobials against tetracycline- and ciprofloxacin-resistant Campylobacter clinical isolates.
Rodríguez-Avial I; Rodríguez-Avial C; López O; Culebras E; Picazo JJ
Int J Antimicrob Agents; 2006 Apr; 27(4):303-6. PubMed ID: 16540293
[TBL] [Abstract][Full Text] [Related]
6. [Antibiotic resistance of bacteria Campylobacter sp].
Rzewuska K; Korsak D; Maćkiw E
Przegl Epidemiol; 2010; 64(1):63-8. PubMed ID: 20499661
[TBL] [Abstract][Full Text] [Related]
7. [Campylobacteriosis and Campylobacter sensitivity to antibiotics].
Taranenko LA; Safonova TB; Spirina TS; Ved'mina EA
Antibiot Khimioter; 1988 Nov; 33(11):862-7. PubMed ID: 3067666
[No Abstract] [Full Text] [Related]
8. Susceptibility of clinical isolates of Campylobacter jejuni to twenty-five antimicrobial agents.
Lariviere LA; Gaudreau CL; Turgeon FF
J Antimicrob Chemother; 1986 Dec; 18(6):681-5. PubMed ID: 3493235
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility of clinical Campylobacter isolates collected at a German university hospital during the period 2006-2008.
Valenza G; Frosch M; Abele-Horn M
Scand J Infect Dis; 2010; 42(1):57-60. PubMed ID: 20055727
[TBL] [Abstract][Full Text] [Related]
10. Resistance to antimicrobial agents of Campylobacter spp. strains isolated from animals in Poland.
Krutkiewicz A; Sałamaszyńska-Guz A; Rzewuska M; Klimuszko D; Binek M
Pol J Vet Sci; 2009; 12(4):465-72. PubMed ID: 20169919
[TBL] [Abstract][Full Text] [Related]
11. [Susceptibility of Campylobacter jejuni clinical isolates from children to eight antibiotics].
García-Campos JA; Alarcón T; Domingo D; Menéndez-Rivas M; López-Brea M
Rev Esp Quimioter; 2003 Jun; 16(2):216-20. PubMed ID: 12973460
[TBL] [Abstract][Full Text] [Related]
12. [Antibiotic resistance of Campylobacter and its epidemiologic significance].
Aleksandrova NZ; Minaev VI; Gorelov AV
Antibiot Khimioter; 1990 Mar; 35(3):34-6. PubMed ID: 2360853
[TBL] [Abstract][Full Text] [Related]
13. Treatment failure of ofloxacin in Campylobacter pylori infection.
Glupczynski Y; Labbe M; Burette A; Delmee M; Avesani V; Bruck C
Lancet; 1987 May; 1(8541):1096. PubMed ID: 2883434
[No Abstract] [Full Text] [Related]
14. EUCAST recommendations for antimicrobial susceptibility testing applied to the three main Campylobacter species isolated in humans.
Sifré E; Salha BA; Ducournau A; Floch P; Chardon H; Mégraud F; Lehours P
J Microbiol Methods; 2015 Dec; 119():206-13. PubMed ID: 26519770
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli strains isolated from two early stages of poultry production.
Pérez-Boto D; García-Peña FJ; Abad-Moreno JC; Echeita MA
Microb Drug Resist; 2013 Aug; 19(4):323-30. PubMed ID: 23391315
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial resistance among Campylobacter strains, United States, 1997-2001.
Gupta A; Nelson JM; Barrett TJ; Tauxe RV; Rossiter SP; Friedman CR; Joyce KW; Smith KE; Jones TF; Hawkins MA; Shiferaw B; Beebe JL; Vugia DJ; Rabatsky-Ehr T; Benson JA; Root TP; Angulo FJ;
Emerg Infect Dis; 2004 Jun; 10(6):1102-9. PubMed ID: 15207064
[TBL] [Abstract][Full Text] [Related]
17. Ciprofloxacin- and azithromycin-resistant Campylobacter causing traveler's diarrhea in U.S. troops deployed to Thailand in 1994.
Murphy GS; Echeverria P; Jackson LR; Arness MK; LeBron C; Pitarangsi C
Clin Infect Dis; 1996 May; 22(5):868-9. PubMed ID: 8722958
[No Abstract] [Full Text] [Related]
18. Trends in antimicrobial resistance in Campylobacter spp. causing traveler's diarrhea.
Ruiz J; Marco F; Oliveira I; Vila J; Gascón J
APMIS; 2007 Mar; 115(3):218-24. PubMed ID: 17367467
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial resistance in Campylobacter spp. isolated from Ontario sheep flocks and associations between antimicrobial use and antimicrobial resistance.
Scott L; Menzies P; Reid-Smith RJ; Avery BP; McEwen SA; Moon CS; Berke O
Zoonoses Public Health; 2012 Jun; 59(4):294-301. PubMed ID: 22273455
[TBL] [Abstract][Full Text] [Related]
20. Drug resistance in Campylobacter jejuni, C coli, and C lari isolated from humans in north west England and Wales, 1997.
Thwaites RT; Frost JA
J Clin Pathol; 1999 Nov; 52(11):812-4. PubMed ID: 10690169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
